Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]
In development
Reference number: GID-TA11553
Expected publication date: TBC
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in early July 2025. The deadline for submissions is expected in approximately mid-September 2025. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission.